Navigation Links
MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
Date:6/29/2009

Prospective Study Seeks to Assess RSV Burden in Outpatient Setting During First Year of Life; Reinforcing Commitment to Pediatric Research

GAITHERSBURG, Md., June 29 /PRNewswire/ -- MedImmune continues to advance its commitment to pediatric research with today's announcement of the first observational prospective study designed to assess the burden of respiratory syncytial virus (RSV) among preterm infants 32-to-35 weeks gestational age (GA) in outpatient settings during their first year of life.

The study also seeks to gather virology data regarding the national onset of the RSV season across the four geographic regions established by the U.S. Centers for Disease Control & Prevention. Additionally, this two-year observational study will look to identify the preterm infants that may be most susceptible to serious RSV infection and the factors that may elevate that risk.

"More than 98 percent of all children contract RSV before their second birthday. Some of these children will be hospitalized and for many more, the severity of the infection forces them to visit a healthcare provider or hospital clinic on an outpatient basis," said Jessie Groothuis, M.D., MedImmune vice president, medical and scientific affairs, infectious disease. "The intent of this first-of-its-kind prospective study is to add to the body of evidence surrounding RSV burden of disease; gaining a snapshot of when the RSV season starts and stops; as well as gathering insight into what risk factors may make preterm infants most susceptible to RSV infection and to serious RSV-related illness."

She went on to say that this information may help pediatricians, payers and health policy makers make better decisions regarding the use of finite healthcare resources on behalf of under-represented and under-served 32-to-35 weeks (GA) preterm infants.

This observational, prospective study will cover two consec
'/>"/>

SOURCE MedImmune
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
2. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
3. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
4. MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results
5. MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
6. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
7. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
8. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
9. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
10. MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
11. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...portlinker.comannouncesthatanewmarketresearchrepor...-GlobalTrends ,, http://www.reportlinker.com..., Widespreadavailabilityofgenericdrugs,emergence...acceleratedthepaceofgrowthinthepainmanagementmarke...uetoshapedemandforservices,drugsanddevices.Themark...
(Date:11/25/2009)...ewswire/-- ChemoCentryx,Inc.,announcedtodaythatPh...ProspectiveRandomizedOralTherapyEvaluationinCrohn,...swithmoderate-to-severeCrohn,sdiseasedemonstratedc...profile.Thestudydemonstratedevidenceofclinicaleffi...pointdecreaseintheCrohn,sDiseaseActivityIndex(CDAI...
(Date:11/24/2009)...-FirstCall/--QuestDiagnosticsIncorporated(NYSE: DG...nformationandservices,announcedthatitisscheduledto...ceinNewYorkCity.ThepresentationisscheduledforWedne...ringtheconference,thecompanywillreaffirmits2009gui...metoexceed18%ofrevenues,anddilutedearningspershare...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Heritage Provider Network and CEO Dr Richard Merkin Featured on Fox News 54812 1Heritage Provider Network and CEO Dr Richard Merkin Featured on Fox News 54812 2Heritage Provider Network and CEO Dr Richard Merkin Featured on Fox News 54812 3Milk is safe even encouraged for some children after treatment for milk allergy 54808 1Milk is safe even encouraged for some children after treatment for milk allergy 54808 2GENova names Aaron Whiteman as CEO 54805 1GENova names Aaron Whiteman as CEO 54805 2GENova names Aaron Whiteman as CEO 54805 3
...(anastrozole) over tamoxifen at preventing all for...me - even four years after ...ta from ATAC*, one of the,world,s largest and long...arly breast cancer, reinforce that anastrozole can.... For the first time, anastrozole has been,shown t...
...ec. 18 Epeius Biotechnologies,Corporation announc... of,their contemporaries in 2007, a truly remarkab...ip, and gonzo journalism. It was a year in,which a...Gene Delivery" was,held at the prestigious Cold Sp... Watson presides, or shall we say presided. The me...
Other Medicine Technology:Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women 2Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women 3Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women 4Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women 5Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine 2Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine 3
(Date:11/25/2009)...TORONTO,Nov.25/PRNewswire/-SentinelleMedicalInc.,a...alizationsoftwarelaunchesasuiteofnewleadingedgecli...areplatformatthisyear,sRadiologicalSocietyofNorthA...09(Booth5800,HallA).Theapplicationsleveragetheuniq...zedMRIimagingcoilsandsupportmultipleimagingmodalit...
(Date:11/25/2009)... BroadPoliticalEndorsements,Business,andPressJoinE...ire-USNewswire/--Onceagain,theNationalBipolarFound...nendorsingtheir"Safe,tilStable"program,whichisnowb...rbipolardisorder.Today,theNationalBipolarFoundatio...ssPriorityMailfromtheLt.GovernorofLouisianaMitchLa...
(Date:11/25/2009)...y follow-up period was too short to draw definite ..., Nov. 25 (HealthDay News) -- In diabetic patients...be no difference in outcomes at one year whether p... stenting, British researchers report. , Bypass...tic patients with coronary artery disease. However...
(Date:11/25/2009)...positive note, CDC sees few signs of trouble with ...5 (HealthDay News) -- The ongoing H1N1 swine flu p... pneumonias among younger patients, a U.S. health ...crease in serious pneumococcal infections around t...tional Center for Immunization and Respiratory Dis...
(Date:11/25/2009)... used to treat colorectal cancer also can reverse ...irst-line therapy for the disease, researchers at ...eek. , Mntrier,s disease causes thickening of the... vomiting, as well as anemia and swelling in the f...t increased risk for gastric cancer. Previously, t...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2
..., Ill., July 11 Caution! If read in its,entirety,...n sick?",(published by AuthorHouse -- http://www....ects: surprise, anger, disbelief and even amusemen...y Do Drugs Cost So Much? and why are we so darn si...
... Allsup outlines missteps that c..., Belleville, Ill. (Vocus)...know what it means to wait. , , , , ,They wait med...ing for Social Security Disability Insurance (SS...
...he-board excellence on U.S. News & World Report ra...,ranking of American hospitals again places the Un...among the country,s finest, with a rank of,13th ov...online today, mark the 13th year in a row that U-M...
...NING PURPOSES ONLY, HOLLYWOOD, Calif., July 10 G...oundation President and CEO Lisa Paulsen, MPAA,Cha...n Services Secretary,Kim Belshe will announce a ma...inment and health leaders. EIF brought,together Pa...
...ding preventive treatment for malaria, given once ...fection and anaemia among schoolchildren, and sign...ing to new research published today in the Lancet...edged. By the time an African child enters school ...
...ON, July 10 The Department of,Justice announced t...d,N.Y., has entered into a settlement agreement wi...ed by parents of children with diabetes who were,t...l or camp on a case-by-case basis, and will make r...
Other Medicine News:Health News:'Why Do Drugs Cost So Much? and why are we so darn sick?': New Book Reveals Inner Workings of Big Pharma, Asks Hard Questions About Our Health 2Health News:Seven Mistakes to Avoid When Seeking Social Security Disability Benefits 2Health News:Seven Mistakes to Avoid When Seeking Social Security Disability Benefits 3Health News:Seven Mistakes to Avoid When Seeking Social Security Disability Benefits 4Health News:Seven Mistakes to Avoid When Seeking Social Security Disability Benefits 5Health News:Seven Mistakes to Avoid When Seeking Social Security Disability Benefits 6Health News:Once Again Among the Nation's Finest: U-M Hospitals & Health Centers Rank 13th in the U.S. 2Health News:Once Again Among the Nation's Finest: U-M Hospitals & Health Centers Rank 13th in the U.S. 3Health News:Malaria prevention reduces anemia and improves educational potential in Kenyan schoolchildren 2Health News:Malaria prevention reduces anemia and improves educational potential in Kenyan schoolchildren 3Health News:Long Island, New York School Agrees To Admit Students With Diabetes 2
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
Medicine Products: